Groundbreaking Agreement for New Tuberculosis Treatment EMERYVILLE, CA and NEW YORK. Chiron Corporation (Nasdaq: CHIR) and the Global Alliance for […]
Multinational pharmaceutical companies and research institutions are racing to meet a 2010 target for developing a new drug to fight
The US-based Global Alliance for TB Drug Development, a one-year old private and public venture participation company has announced that
Several India pharma companies feature in the line up to develop new molecule for drug resistant tuberculosis, which is going
TB Alliance co-hosted a discussion of “Current Developments in Drug Discovery for Tuberculosis” organized by AstraZeneca Research Foundation-India. CEO Dr.
Once thought to be a disease of the past, tuberculosis is now a front burner health problem. With 8.4 million
New York, Jan. 1 – In his memoirs, Alexandre Dumas observed wryly that “it was all the fashion to suffer
2001 DEC 16 – Fueled by the growing tuberculosis epidemic, the market for drugs to treat TB will approach $700
Though not huge, size should draw interest, say authors An exhaustive new report on the size of the world market
The Global Alliance for TB Drug Development has published a report it believes will revive he interest of the pharmaceutical
